or Try an Advanced Search...

    Technical Analysis for PCVX - Vaxcyte, Inc.

    Grade Last Price % Change Price Change
    B 76.94 1.89% 1.43
    PCVX closed up 1.89 percent on Monday, July 1, 2024, on 1.31 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical PCVX trend table...
    Date Alert Name Type % Chg
    New Uptrend Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Cup with Handle Other 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Cup with Handle Other 1.89%
    Volume Surge Other 1.89%
    Upper Bollinger Band Walk Strength 1.89%
    Outside Day Range Expansion 1.89%
    Upper Bollinger Band Touch Strength 1.89%
    Older End-of-Day Signals for PCVX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Upper Bollinger Band about 4 hours ago
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    1.5x Volume Pace about 10 hours ago
    Up 2% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PCVX Chart by TradingView
    Basic chart:

    Profile

    Vaxcyte, Inc. a biopharmaceutical company, develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate, and complex antigen-based vaccines. The company has a license to Sutro Biopharma's Xpress CF platforms for cell free protein synthesis and site-specific conjugation. Vaxcyte, Inc. was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May, 2020. The company was incorporated in 2013 and is based in Foster City, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Infectious Diseases Vaccines Vaccination Virology

    Is PCVX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 24 Vaxcyte files for a mixed shelf offering
    May 10 Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview
    May 9 Vaxcyte GAAP EPS of -$0.85
    May 8 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
    May 4 Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares
    Apr 10 Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
    Apr 7 Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
    Apr 2 Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
    Mar 27 Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
    Mar 20 Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares
    See more PCVX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 82.04
    52 Week Low 44.2
    Average Volume 735,892
    200-Day Moving Average 62.38
    50-Day Moving Average 69.52
    20-Day Moving Average 73.69
    10-Day Moving Average 74.84
    Average True Range 2.77
    RSI (14) 60.47
    ADX 25.75
    +DI 28.73
    -DI 12.53
    Chandelier Exit (Long, 3 ATRs) 71.48
    Chandelier Exit (Short, 3 ATRs) 76.27
    Upper Bollinger Bands 77.64
    Lower Bollinger Band 69.74
    Percent B (%b) 0.91
    BandWidth 10.73
    MACD Line 1.82
    MACD Signal Line 1.61
    MACD Histogram 0.2082
    Fundamentals Value
    Market Cap 8.3 Billion
    Num Shares 108 Million
    EPS -4.73
    Price-to-Earnings (P/E) Ratio -16.27
    Price-to-Sales 0.00
    Price-to-Book 5.76
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 80.30
    Resistance 3 (R3) 80.10 78.77 79.74
    Resistance 2 (R2) 78.77 77.92 78.88 79.55
    Resistance 1 (R1) 77.86 77.39 78.32 78.06 79.37
    Pivot Point 76.53 76.53 76.76 76.64 76.53
    Support 1 (S1) 75.62 75.68 76.08 75.82 74.51
    Support 2 (S2) 74.29 75.15 74.40 74.33
    Support 3 (S3) 73.38 74.29 74.14
    Support 4 (S4) 73.58